4-AMINO-1-[(2-CHLOROPHENYL)METHYL]PYRROLIDIN-2-ONE, 95.0%, 10g

(1H-Pyrrolo[3,2-b]pyridin-6-yl)methanol, 98+%, 50mg

TERT-BUTYL (E)-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)ALLYL)CARBAMATE, 95.0%, 1g

1-[(2S)-2-aminopropyl]pyrrolidin-2-one hydrochloride, 95.0%, 1g

1,1-Di(o-tolyl)ethylene, 1g

4-HYDROXY-1-(PYRIDIN-3-YL)BUTAN-1-ONE, 95.0%, 1g

5-(2-(Trifluoromethyl)phenyl)isoxazole, 98%, 10g

10-Methylanthracene-9-carbaldehyde, 97%, 1g

GC capillary column ROTI®Cap-5, 30 m, 0.32 mm, 3.00 µm, 1 Piece(s)

2-(4-Bromo-2,6-difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98.0%, 5g

2-Bromo-4-methylphenol, 95.0%, 5g

2-(3-Chloro-phenoxy)-thiazole-4-carboxylic acid phenylamide, 95.0%, 5g

4-Benzyloxy-2-fluorophenylboronic Acid (contains varying amounts of Anhydride)1g